Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
12/2012
12/25/2012US8338481 Alkoxyalkyl S-prenylthiosalicylates for treatment of cancer
12/25/2012US8338366 Bioactive FUS1 peptides and nanoparticle-polypeptide complexes
12/25/2012US8337811 Pharmaceutical composition of nanoparticles
12/25/2012US8337810 Stabilized compositions and methods for radiolabeling pharmaceuticals with alpha-particle emitters
12/25/2012US8337809 Charge-assembled capsules for phototherapy
12/20/2012WO2012174557A1 Inhalable pharmaceutical compositions
12/20/2012WO2012174285A2 Inhibitor probes for imaging sodium-glucose cotransporters in health and disease
12/20/2012WO2012173933A2 Activatable nanoprobes for intracellular drug delivery
12/20/2012WO2012173762A1 Cyclic lactadherin peptide mimetics and their uses
12/20/2012WO2012173222A1 Gallium-labeled drug
12/20/2012WO2012172283A1 Method of labelling a biologically active molecule with 5 - fluoro - 5 - deoxypentose or a 3 - fluoro - 3 - deoxypentose
12/20/2012WO2012172271A1 Bifunctional phosphonate chelating agents
12/20/2012US20120321561 Cancer diagnosis and imaging
12/20/2012US20120321560 Method for Obtaining Novel Derivatives of Naphthalene for the In Vivo Diagnosis of Alzheimer's Disease
12/20/2012US20120321559 Hexahydro-pyrrolo-isoquinoline compounds
12/20/2012US20120321558 Compositions of high specific activity sn-117m and methods of preparing the same
12/20/2012US20120321557 Anti-icam3 antibody and use thereof
12/20/2012US20120321556 Enhanced Cytotoxicity of Anti-CD74 and Anti-HLA-DR Antibodies with Interferon-Gamma
12/20/2012US20120321555 Treatment and prophylaxis of amyloidosis
12/20/2012US20120321554 Plexin d1 as a target for tumor diagnosis and therapy
12/20/2012US20120321553 Ultrafiltration Concentration of Allotype Selected Antibodies for Small-Volume Administration
12/20/2012US20120321552 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
12/20/2012CA2839191A1 Method of labelling a biologically active molecule with 5 - fluoro - 5 - deoxypentose or a 3 - fluoro - 3 - deoxypentose
12/19/2012EP2535358A1 Radioactive metal-labeled anti-cadherin antibody
12/19/2012EP2533817A2 Alpha-emitting complexes
12/19/2012EP2533816A1 F18-tyrosine derivatives for imaging bone metastases
12/19/2012EP2533810A1 Cd20 antibodies and uses thereof
12/19/2012EP2533764A1 Biomineral and metal binding liposomes, their synthesis, and methods of use thereof
12/19/2012CN102834379A Tricyclic indole derivatives as PBR ligands
12/19/2012CN102834120A Imaging the central nervous system with purinergic P2X7 receptor binding agents
12/19/2012CN102834119A Radiopharmaceutical concentration measurement system and method
12/19/2012CN102827208A Preparation method and application of 99mTcO-core-labeled methionine dithiocarbamate complex
12/19/2012CN102827166A 18F-labelled folates
12/19/2012CN101885744B Preparation method of 99mTc labeled hydrazinonicotinamide group-pteroyllysine complex
12/18/2012US8334253 Cosmetic and dermatological formulations of MNTF peptides
12/18/2012US8334000 Anti-angiogenic extracts from pomegranate
12/18/2012US8333996 Adjust particle size; induce immunology response; vaccines
12/18/2012US8333952 Dose synthesis module for biomarker generator system
12/18/2012US8333697 Diagnostic kits and methods for diagnosis of axial pain with or without radiculopathy
12/13/2012WO2012168464A1 Imaging and treatment of neuroendocrine tumors with glucose - dependent insulinotropic polypeptide or analogues or antagonists thereof
12/13/2012WO2012168196A1 Production and use of a peptide having an n-terminal 11c-marked acetyl
12/13/2012WO2012167350A1 Method for the synthesis of porphyrin-phospholipid conjugates
12/13/2012US20120315217 Inverse agonists and neutral antagonists for the tsh receptor
12/13/2012US20120315216 Compositions and Methods for Treating and Diagnosing Cancer
12/13/2012CA2837901A1 Method for the synthesis of porphyrin-phospholipid conjugates
12/12/2012EP2531449A1 METHOD AND DEVICE FOR PRODUCING 99mTc
12/12/2012CN102821815A Treatment of chronic inflammatory conditions
12/12/2012CN102380111B Method for preparing <125>I mark product for ferroferric oxide nanoparticles and application thereof
12/12/2012CN101657552B Method for the elution of 18F fluoride trapped on an anion-exchange resin in a form suitable for efficient radiolabeling without any evaporation step
12/12/2012CN101454026B Novel imaging agents
12/11/2012US8329863 Gonadotropin releasing hormone antagonists
12/11/2012US8329172 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody
12/11/2012US8329142 Compounds, compositions and methods for medical imaging of Parkinson's disease
12/11/2012US8329141 Locoregional internal radionuclide ablation of abnormal tissues
12/11/2012CA2520144C Microspheres comprising therapeutic and diagnostic radioactive isotopes
12/11/2012CA2362119C Radiolabeling kit and binding assay
12/06/2012WO2012163773A1 Radiolabelled glutaminyl cyclase inhibitors
12/06/2012WO2012162820A1 Maleimide-functionalized gold nanoparticles
12/06/2012US20120309628 Bioactive agent delivery particles
12/06/2012US20120308481 Radio-opaque compounds, compositions containing same and methods of their synthesis and use
12/06/2012US20120308480 Humanized antibodies against tl1a
12/06/2012US20120308479 Brain Endothelial Cell Expression Patterns
12/06/2012US20120308478 Antibodies specific for claudin 6 (cldn6)
12/06/2012US20120308477 Brief radioimmunotherapy
12/06/2012DE102011076808A1 Anordnung zur automatischen Handhabung radioaktiver Stoffe Arrangement for automatic handling of radioactive materials
12/06/2012DE102011050848A1 Schichtaufbau zur epidermalen Radionuklidtherapie Layer structure for epidermal radionuclide therapy
12/06/2012CA2837472A1 Rationally-designed anti-mullerian inhibiting substance type ii receptor antibodies
12/06/2012CA2835014A1 Radiolabelled glutaminyl cyclase inhibitors
12/05/2012EP2529758A2 Vitamin receptor binding drug delivery conjugates
12/05/2012EP2528627A2 Radioimmunoconjugates and uses thereof
12/05/2012CN102811707A Biomineral and metal binding liposomes, their synthesis, and methods of use thereof
12/04/2012US8324153 Antiviral cell-penetrating peptides
12/04/2012US8323913 Marker for inflammatory conditions
12/04/2012US8323617 Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
12/04/2012US8323616 Solid-phase fluorination of benzothiazoles
12/04/2012US8323615 Methods of processing multi-phasic dispersions
12/04/2012CA2622760C Cyclopropyl amines as modulators of the histamine h3 receptor
12/04/2012CA2590620C Stabilised 99mtc compositions
12/04/2012CA2501282C Vasoregulating compounds and methods of their use
11/2012
11/29/2012WO2012162583A1 Design and construction of novel multivalent antibodies
11/29/2012WO2012162426A1 Methods and compositions for heptameric targeting ligands
11/29/2012WO2012162418A1 Methods and compositions for heterodimeric targeting ligands
11/29/2012WO2012161177A1 Labeled derivative for image diagnosis of tumor
11/29/2012WO2012161116A1 Novel compound having affinity for amyloid
11/29/2012US20120301399 Method for production of radiation diagnostic imaging agent
11/29/2012US20120301398 Radiolabelled glutaminyl cyclase (qc) inhibitors and uses of same
11/29/2012US20120301397 Diagnosis of macrophage mediated disease
11/29/2012US20120301396 Radioimmunoconjugates and uses thereof
11/29/2012US20120301395 Monoclonal Antibodies Against PCBP-1 Antigens, and Uses Therefor
11/29/2012US20120301394 Targeting and in vivo imaging of tumor-associated macrophages
11/29/2012US20120301393 Modified ubiquitin proteins having a specific binding activity for the extradomain b of fibronectin
11/29/2012CA2836872A1 Novel compound having affinity for amyloid
11/28/2012EP2525820A1 Novel class of monospecific and bispecific humanized antibodies that target the insulin-like growth factor type i receptor (igf-1r)
11/28/2012CN1816357B Thermogelling polymer blends for biomaterial applications
11/28/2012CN102802673A PET imaging of fibrogenesis
11/28/2012CN102796175A Polypeptide bound with high affinity of vasoactive intestinal peptide I type acceptor and application
11/28/2012CN101646625B Production of thorium 228 starting from a natural thorium salt
11/28/2012CN101365490B Hydrophobic core carrier compositions for delivery of therapeutic agents, methods of making and using the same
11/27/2012US8318160 Treatment of cancer with novel anti-IL13 monoclonal antibodies
11/27/2012US8318133 Macrocyclic cyanine and indocyanine bioconjugates provide improved biomedical applications
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 ... 243